Emulation Trials in SLE: Real or Fake Dr. Janet Pope, Ontario, Canada, discusses emulation trials in systemic lupus er

Social Author Image
https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
Tweet Author
RheumNow
Social Author Name
Dr. John Cush
Tweet Content
Emulation Trials in SLE: Real or Fake Dr. Janet Pope, Ontario, Canada, discusses emulation trials in systemic lupus erythematosus. https://t.co/wVmMfLVAuQ https://t.co/V4VGVncSE9
Links
Emulation Trials in SLE: Real or Fake | RheumNow https://buff.ly/mHykPEp

2024 ACR Lupus Nephritis Guidelines: The Controversies Drs. Maria Dall’Era & Michelle Petri discuss the sticking

Social Author Image
https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
Tweet Author
RheumNow
Social Author Name
Dr. John Cush
Tweet Content
2024 ACR Lupus Nephritis Guidelines: The Controversies Drs. Maria Dall’Era & Michelle Petri discuss the sticking points in the latest lupus nephritis recommendations. 🗣️ Insightful, honest, and essential for your practice. 📍Full update on RheumNow: https://t.co/KPjyCrMTBr https://t.co/VoOslSqs99
Links
Lupus Nephritis | RheumNow https://buff.ly/EFmVnVw
29 May 2025
CNS Lupus (NPSLE)
29 yr. old woman with SLE and transverse myelitis. Is this NPSLE; how to diagnose?

CNS Lupus (NPSLE)

IMPACT Study - Certolizumab Efficacy in APS Pregnancies A pilot trial assessed the safety and value of tumour necrosis

Social Author Image
https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
Tweet Author
RheumNow
Social Author Name
Dr. John Cush
Tweet Content
IMPACT Study - Certolizumab Efficacy in APS Pregnancies A pilot trial assessed the safety and value of tumour necrosis factor α inhibitor treatment with certolizumab in patients with high-risk pregnancies with antiphospholipid syndrome (APS). Certolizumab (CZP) was shown to https://t.co/sbXW6vNX5y
29 May 2025
Belimumab in SLE with Mucocutaneous or Vasculitis Findings
A post hoc analysis of a belimumab (BEL) inn systemic lupus erythematosus (SLE) study showed lupus mucocutaneous and vasculitic manifestations improve with BEL and standard care.
29 May 2025
Valves Gone Wild in SLE
Lupus valvulitis is a rare cardiac manifestation of active systemic lupus erythematosus (SLE) and is defined by inflammation of one or more cardiac valves. It is often associated with Libman-Sacks endocarditis, which is characterized by the presence of sterile vegetations on the heart valves.

Moving Targets in Lupus and Lupus Trials In the 1990s, developing lupus treatments became a priority, but success was

Social Author Image
https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
Tweet Author
RheumNow
Social Author Name
Dr. John Cush
Tweet Content
Moving Targets in Lupus and Lupus Trials In the 1990s, developing lupus treatments became a priority, but success was elusive for 20 years. Belimumab was approved by showing only small differences from placebo in trials with 867 patients globally. Its efficacy was confirmed by https://t.co/TekxzTJjwC

NEW for #LUPUS2025—@ern_reconnet–SLICC–@SLEuroSociety expert consensus on the therapeutic management of rare syste

Social Author Image
https://pbs.twimg.com/profile_images/1117737372827910146/fI-WDgjl_normal.png
Tweet Author
TheLancetRheum
Social Author Name
The Lancet Rheumatology
Tweet Content
NEW for #LUPUS2025—@ern_reconnet–SLICC–@SLEuroSociety expert consensus on the therapeutic management of rare systemic #lupus erythematosus manifestations https://t.co/XwAHpsho57 Free to read with registration on https://t.co/28wkm5ab69 (also free) @Lupusreference #SLE https://t.co/73K0DKTHye
Links
ERN ReCONNET–SLICC–SLEuro expert consensus on the therapeutic management of rar… https://bit.ly/3YXEmAO
The Lancet | The best science for better lives http://lancet.com
https://x.com/TheLancetRheum/status/1926258127114293544/photo/1
Subscribe to
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×